BAUSCH HEALTH COMPANIES INC
BAUSCH HEALTH COMPANIES INC/ CA0717341071 /
BHC
|
6/24/2022 10:00:01 PM
|
Chg.
+1.83
|
Volume |
Bid10:14:59 PM |
Ask10:14:59 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
11.28CAD
|
+19.37%
|
1.64 mill.
Turnover: 17.93 mill. |
11.00Bid Size: 500 |
11.30Ask Size: 700 |
4.02 bill.CAD |
- |
- |
Business description
Bausch Health Companies Inc. is a global company whose mission is to improve people's lives with health care products. Bausch develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
Management board & Supervisory board
| CEO |
| Joseph C. Papa |
| Management board |
| Sam Eldessouky, Barbara Purcell, Christina Ackermann, Dennis Asharin, Dr. Louis Yu, Dr. Tage Ramakrishna, Jeff Hartness, Joseph Gordon, Kelly Webber, Paul S. Herendeen, Robert Spurr, Scott Hirsch, Thomas Appio |
| Supervisory board |
| Joseph C. Papa, Amy B. Wechsler, M.D., Andrew C. von Eschenbach, M.D., Brett Icahn, Dr. Argeris N. Karabelas, John A. Paulson, Richard U. DeSchutter, Robert N. Power, Russel C. Robertson, Sarah B. Kavanagh, Steven D. Miller, Thomas W. Ross |
Company data
| Name: |
Bausch Health Companies Inc. |
| Address: |
2150 St. Elzéar Blvd. West,Laval, Quebec H7L 4A8, Canada |
| Phone: |
+1-514-744-6792 |
| Fax: |
+1-514-744-6272 |
| E-mail: |
-
|
| Internet: |
https://www.bauschhealth.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12/31 |
| Free Float: |
- |
| IPO date: |
- |
Main Shareholders
| Freefloat |
|
78.09% |
| Icahn Associates Holding LLC, |
|
9.59% |
| Paulson & Co. Inc. |
|
7.27% |
| VA Partners I, LLC |
|
5.05% |